1. Home
  2. REFI vs VYGR Comparison

REFI vs VYGR Comparison

Compare REFI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chicago Atlantic Real Estate Finance Inc.

REFI

Chicago Atlantic Real Estate Finance Inc.

HOLD

Current Price

$11.36

Market Cap

253.6M

Sector

Real Estate

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.81

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REFI
VYGR
Founded
2021
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.6M
227.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
REFI
VYGR
Price
$11.36
$3.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
138.3K
511.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
15.79%
N/A
EPS Growth
N/A
N/A
EPS
0.23
N/A
Revenue
$48,857,628.00
$10,135,000.00
Revenue This Year
$17.47
$34.04
Revenue Next Year
$0.06
$7.92
P/E Ratio
$49.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.74
$2.65
52 Week High
$14.97
$5.55

Technical Indicators

Market Signals
Indicator
REFI
VYGR
Relative Strength Index (RSI) 41.80 47.93
Support Level $10.74 $3.71
Resistance Level $12.45 $4.39
Average True Range (ATR) 0.29 0.27
MACD -0.04 -0.03
Stochastic Oscillator 18.75 40.23

Price Performance

Historical Comparison
REFI
VYGR

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: